CAV2
Overview
```mermaid
flowchart TD
classDef gene fill:#0a1f0a,stroke:#4caf50
classDef protein fill:#0a1929,stroke:#2196f3
classDef disease fill:#2d0f0f,stroke:#e91e63
classDef pathway fill:#3e2200,stroke:#ff9800
classDef mechanism fill:#1a0a1f,stroke:#9c27b0
classDef therapeutic fill:#e0f2f1,stroke:#009688
CAV2["CAV2"] -->|"implicated_in"| neurodegeneration["neurodegeneration"]
CAV2["CAV2"] -.->|"inhibits"| Alzheimer["Alzheimer"]
CAV2["CAV2"] -.->|"inhibits"| Ms["Ms"]
CAV2["CAV2"] ==>|"activates"| PIK3C3["PIK3C3"]
CAV2["CAV2"] ==>|"activates"| Als["Als"]
CAV2["CAV2"] -->|"regulates"| Aging["Aging"]
CAV2["CAV2"] -->|"regulates"| Cancer["Cancer"]
CAV2["CAV2"] ==>|"activates"| Mapk["Mapk"]
CAV2["CAV2"] -.->|"inhibits"| TAU["TAU"]
CAV2["CAV2"] -.->|"inhibits"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
CAV2["CAV2"] -.->|"inhibits"| ALZHEIMER["ALZHEIMER"]
CAV2["CAV2"] -.->|"inhibits"| AMYLOID["AMYLOID"]
CAV2["CAV2"] -->|"causes"| GENES["GENES"]
CAV2["CAV2"] -->|"associated_with"| AND["AND"]
CAV2["CAV2"] -->|"causes"| Ms["Ms"]
CAV2["CAV2"] -->|"causes"| Als["Als"]
CAV2["CAV2"] -->|"causes"| Glaucoma["Glaucoma"]
CAV2["CAV2"] -->|"co_discussed"| CAV2_3["CAV2.3"]
CAV2["CAV2"] -->|"co_discussed"| NEURON["NEURON"]
CAV2["CAV2"] -->|"co_discussed"| STING["STING"]
CAV2["CAV2"] -.->|"inhibits"| AND["AND"]
CAV2["CAV2"] -.->|"inhibits"| Amyloid["Amyloid"]
CAV2["CAV2"] -->|"expressed_in"| Ca1["Ca1"]
CAV2["CAV2"] -->|"expressed_in"| Neuron["Neuron"]
CAV2["CAV2"]
...CAV2
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CAV2</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Residues</td>
</tr>
<tr>
<td class="label">N-terminal scaffolding domain</td>
<td>1-75</td>
</tr>
<tr>
<td class="label">Hydrophobic domain</td>
<td>76-103</td>
</tr>
<tr>
<td class="label">C-terminal domain</td>
<td>104-162</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Golgi localization</td>
<td>CAV2 cycles through the Golgi apparatus</td>
</tr>
<tr>
<td class="label">Vesicular trafficking</td>
<td>Independent of classical caveolae</td>
</tr>
<tr>
<td class="label">Signaling modulation</td>
<td>Distinct downstream pathways</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>CAV2 Interaction</td>
</tr>
<tr>
<td class="label">MAPK/ERK</td>
<td>Modulates downstream signaling</td>
</tr>
<tr>
<td class="label">PI3K/Akt</td>
<td>Sequesters specific effectors</td>
</tr>
<tr>
<td class="label">G proteins</td>
<td>Distinct G protein coupling</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>CAV1</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous</td>
</tr>
<tr>
<td class="label">Caveolae formation</td>
<td>Yes</td>
</tr>
<tr>
<td class="label">Genomic location</td>
<td>7q31.1</td>
</tr>
<tr>
<td class="label">Main functions</td>
<td>Signaling hub</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">Signaling modulators</td>
<td>Target CAV2-associated pathways</td>
</tr>
<tr>
<td class="label">Delivery vectors</td>
<td>Use caveolae for drug delivery</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Modulate expression</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">CAV1</td>
<td>Heterodimer</td>
</tr>
<tr>
<td class="label">CAV2</td>
<td>Homodimer</td>
</tr>
<tr>
<td class="label">Cholesterol</td>
<td>Binding</td>
</tr>
<tr>
<td class="label">G proteins</td>
<td>Scaffold</td>
</tr>
<tr>
<td class="label">EGFR</td>
<td>Scaffold</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/glaucoma" style="color:#ef9a9a">Glaucoma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">26 edges</a></td>
</tr>
</table>
CAV2 encodes Caveolin-2, the second member of the caveolin protein family that co-assembles with Caveolin-1 (CAV1) to form functional caveolae at the plasma membrane. Located on chromosome 7q31.1, adjacent to the CAV1 gene, CAV2 is expressed ubiquitously but at lower levels than CAV1. While CAV1 is sufficient for caveolae formation, CAV2 stabilizes and modulates caveolar function, and has distinct signaling roles that complement its partner caveolin["@Parton2018"][@Williams2004].
The caveolin gene family (CAV1, CAV2, CAV3) arose from a common ancestor through gene duplication, with CAV2 and CAV1 being particularly closely linked—located in the same genomic region and often co-expressed. CAV2's functions are intertwined with CAV1 but also include unique aspects, particularly in cellular trafficking, Golgi function, and specific signaling pathways. In the nervous system, CAV2 contributes to neuronal signaling and has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD)[@Gaudreault2008][@Garcia2009].
Molecular Structure and Function
Protein Architecture
Caveolin-2 shares structural homology with CAV1 but has distinct features:
CAV2 (∼18 kDa) differs from CAV1 in:
- Shorter N-terminus: 75 vs 81 residues
- Alternative splicing: Produces β- and γ-isoforms
- Different post-translational modifications
CAV1-CAV2 Interaction
CAV2 functions primarily as a heterodimer with CAV1:
Complex formation: CAV1-CAV2 heterodimers assemble into caveolae
Stabilization: CAV2 stabilizes CAV1 oligomers
Modulation: Alters signaling within caveolae
Trafficking: Directs CAV2 to specific cellular locationsDistinct CAV2 Functions
While requiring CAV1 for caveolae formation, CAV2 has independent functions:
Role in Cellular Processes
CAV2 contributes to caveolae through[@Cohen2004]:
Heterodimerization: Forms complexes with CAV1
Co-oligomerization: ~14-16 heterodimers per caveola
Stabilization: Increases caveolar stability
Modulation: Alters caveolar size and dynamicsSignal Transduction
CAV2 organizes distinct signaling complexes:
Endocytosis and Trafficking
CAV2 has unique trafficking properties[@Fujimoto2000]:
- Golgi cycling: Transient Golgi localization
- Endosomal sorting: Directs cargo to specific destinations
- Non-caveolar functions: Independent of classic caveolae
Role in the Nervous System
Neuronal Expression
CAV2 is expressed in neurons and glia:
- Neurons: Pyramidal cells, interneurons
- Astrocytes: Particularly around blood vessels
- Oligodendrocytes: Lower expression
- Microglia: Activation-dependent
Synaptic Function
CAV2 contributes to synaptic biology:
Receptor organization: Scaffolds neurotransmitter receptors
Signal modulation: Regulates postsynaptic signaling
Endocytosis: Mediates receptor internalizationBlood-Brain Barrier
CAV2 participates in BBB function:
- Endothelial cells: Works with CAV1 at the BBB
- Transport: Regulates transcytosis
- Tight junctions: Maintains barrier integrity
Disease Associations
Alzheimer's Disease
CAV2 connections to AD include[@Gaudreault2008]:
Cholesterol metabolism: Caveolae in cholesterol homeostasis
APP processing: Possible interactions with amyloidogenesis
Signal dysregulation: Altered caveolar signaling
Neuroinflammation: Modulates inflammatory responsesParkinson's Disease
CAV2 may contribute to PD[@Garcia2009]:
Dopaminergic signaling: Modulates receptor signaling
Mitochondrial function: Possible connections
Synaptic plasticity: Affects dopamine transmissionCancer
CAV2 has prominent roles in cancer biology[@Krajewska2008]:
- Proliferation: Promotes cell growth
- Metastasis: Associated with invasion
- Angiogenesis: Modulates blood vessel formation
- Therapy resistance: Linked to drug resistance
Caveolin Family Comparison
Expression and Regulation
Tissue Distribution
CAV2 expression:
- Endothelial cells: High (with CAV1)
- Epithelial cells: Moderate
- Neurons: Low-moderate
- Fibroblasts: Variable
Transcriptional Regulation
CAV2 is regulated by:
CAV1 expression: Co-regulated with CAV1
Common promoters: Shared regulatory elements
Cell-type specific factors: Different from CAV1Therapeutic Implications
Drug Targets
CAV2 offers therapeutic opportunities:
Challenges
- Specificity: Targeting CAV2 vs CAV1
- Function overlap: Redundancy with CAV1
- BBB penetration: Delivery to the brain
Interaction Network
CAV2 interacts with:
Research Directions
Unresolved Questions
Specific functions: Unique roles of CAV2 vs CAV1
Disease contributions: Direct mechanisms in neurodegeneration
Therapeutic targeting: Best strategiesEmerging Areas
- Super-resolution microscopy: Caveolar organization
- Single-cell analysis: Cell-type specific functions
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Caveolin-2 Protein](/proteins/cav2-protein)
- [CAV1](/genes/cav1) - Primary caveolin
- [CAV3](/genes/cav3) - Muscle-specific caveolin
- [Caveolae](/mechanisms/caveolae)
- [Signal Transduction](/mechanisms/signal-transduction)
- [Blood-Brain Barrier](/mechanisms/blood-brain-barrier)
External Links
- [Ensembl: ENSG00000105968](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000105968)
- [UniProt: P51636](https://www.uniprot.org/uniprot/P51636)
- [GeneCards: CAV2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CAV2)
- [OMIM: 601048](https://www.omim.org/entry/601048)
- [NCBI Gene: 858](https://www.ncbi.nlm.nih.gov/gene/858)
References
[Parton & del Pozo, Caveolae as plasma membrane sensors (2018)](https://doi.org/10.1038/s41580-018-0003-4)
[Stern et al., Caveolin functions in development and disease (2019)](https://doi.org/10.1093/hmg/ddz108)
[Williams & Lisanti, The caveolin genes (2004)](https://doi.org/10.1016/j.tcb.2004.08.005)
[Head et al., Caveolin in neurodegenerative diseases (2011)](https://doi.org/10.1016/j.yjmcc.2011.02.012)
[Gaudreault et al., Caveolin in Alzheimer's disease (2008)](https://pubmed.ncbi.nlm.nih.gov/18654095/)
[Garcia et al., Caveolin in Parkinson's disease (2009)](https://doi.org/10.1016/j.parkreldis.2008.09.018)
[Trimmer et al., Caveolin in lipid metabolism (2019)](https://doi.org/10.1152/physrev.00037.2018)
[Patel et al., Caveolae as signal organizers (2008)](https://doi.org/10.1146/annurev.pharmtox.48.121505.105224)
[Cohen et al., Role of caveolae and caveolins in health and disease (2004)](https://doi.org/10.1152/physrev.00040.2003)
[Krajewska et al., Caveolin-2 in cancer (2008)](https://doi.org/10.1016/S0065-230X(08)00004-3)
[Fujimoto et al., Caveolin-2 localizes to the Golgi (2000)](https://pubmed.ncbi.nlm.nih.gov/10627546/)Pathway Diagram
The following diagram shows the key molecular relationships involving CAV2 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)